Tumour lysis syndrome.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000378:metabolism*; D008659:Metabolic Diseases / Q000139:chemically induced*; D013577:Syndrome
D000970:Antineoplastic Agents